Deprescribing for older patients

CMAJ

Volumn 186, Issue 18, 2014, Pages 1369-1376

  Frank, Christopher ^a   Weir, Erica ^b  

^a St Mary's of the Lake Hospital   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; DIURETIC AGENT; NEUROLEPTIC AGENT;

DEPRESCRIBING; DRUG INDICATION; ELDERLY CARE; HUMAN; INAPPROPRIATE PRESCRIBING; MEDICATION ERROR; NURSE; PATIENT PREFERENCE; PHARMACEUTICAL CARE; PHARMACIST; PHYSICIAN; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PROTOCOL COMPLIANCE; QUALITY OF LIFE; REVIEW; RISK REDUCTION; TREATMENT PLANNING; TREATMENT WITHDRAWAL; AGED; DECISION TREE; STANDARDS;

AGED; DECISION TREES; DRUG PRESCRIPTIONS; HUMANS; POLYPHARMACY; WITHHOLDING TREATMENT;

EID: 84918807621     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.131873     Document Type: Article

References (47)

1. Principles of prescribing for elderly people. BPJ 2008;11:10-3. Available: www.bpac.org.nz/BPJ/2008/February/prescribing.aspx (accessed 2014 Aug 20).
2. Medication use and the elderly (update 2000) [policy]. Ottawa: Canadian Medical Association; 2000. Available: http://policy base.cma.ca/dbtw-wpd/PolicyPDF/PD01-04.pdf (accessed 2014 Aug 20).
3. Montastruc JL, Montastruc F. Prescribe, but also know how to "deprescribe." Prescrire Int 2013;22:192.
4. Woodward M. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res 2003;33:323-8.
5. Cross C. Introducing deprescribing into culture of medication. CMAJ 2013;185:E606.
6. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-310.
7. Hamilton HJ, Gallagher PF, O'Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatr 2009;9:5.
8. Tamura BK, Bell CL, Inaba M, et al. Outcomes of polypharmacy in nursing home residents. Clin Geriatr Med 2012;28:217-36.
9. Lai SW, Liao KF, Liao CC, et al. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore) 2010;89:295-9.
10. Huang ES, Karter AJ, Danielson KK, et al. The association between the number of prescription medications and incident falls in a multi-ethnic population of adult type-2 diabetes patients: the diabetes and aging study. J Gen Intern Med 2010; 25:141-6.
11. Ramage-Morin PL. Medication use among senior Canadians. Health Rep 2009;20:37-44.
12. Rockwood K, Stadnyk K, MacKnight C, et al. A brief clinical instrument to classify frailty in elderly people. Lancet 1999; 353:205-6.
13. Gnjidic D, Le Couteur DG, Kouladjian L, et al. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med 2012;28:237-53.
14. Tjia J, Velten SJ, Parsons C, et al. Studies to reduce unnecessary medication use in frail older adults: a systematic review. Drugs Aging 2013;30:285-307.
15. Steinman MA, Hanlon JT. Managing medications in clinically complex elders: "There's got to be a happy medium." JAMA 2010; 304:1592-601.
16. Iyer S, Naganathan V, McLachlan AJ, et al. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 2008;25:1021-31.
17. Koller K, Rockwood K. Frailty in older adults: implications for end-of-life care. Cleve Clin J Med 2013;80:168-74.
18. Gurwitz JH. The physics of geriatric pharmacotherapy: overcoming therapeutic inertia and momentum. Am J Med 2012; 125:523-4.
19. Desai R, Williams CE, Greene SB, et al. Medication errors during patient transitions into nursing homes: characteristics and association with patient harm. Am J Geriatr Pharmacother 2011; 9:413-22.
20. Gleason KM, McDaniel MR, Feinglass J, et al. Results of the Medications at Transitions and Clinical Handoffs (MATCH) study: an analysis of medication reconciliation errors and risk factors at hospital admission. J Gen Intern Med 2010;25:441-7.
21. Turner J, Singhal N, Bell J. Opportunities for depresribing statins in patients with poor cancer prognosis. J Palliat Med 2013; 16:1328.
22. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294: 716-24.
23. Campbell AJ, Robertson MC, Gardner MM, et al. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc 1999; 47:850-3.
24. Salzman C, Fisher J, Nobel K, et al. Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. Int J Geriatr Psychiatry 1992;7:89-93.
25. Chertkow H, Massoud F, Nasreddine Z, et al. Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ 2008;178:1273-85.
26. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guidelines for the management of blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311: 507-20.
27. Aronow WS, Fleg J, Pepine C, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2011; 123: 2434-506.
28. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2013;3(Suppl 1):S1-211.
29. Tinetti ME, Doucette J, Claus E, et al. Risk factors for serious fall injury among community elderly persons. J Am Geriatr Soc 1995; 43:1214-21.
30. Declercq T, Petrovic M, Azermai M, et al. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev 2013;(3):CD007726.
31. Patterson SM, Hughes C, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012;(5):CD008165.
32. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616-31.
33. Tinetti ME, McAvay GJ, Fried TR. Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes. J Am Geriatr Soc 2008;56:1409-16.
34. Gallagher P, O'Mahony D. STOPP (screening tool of older persons' potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008;37:673-9.
35. Gokula M, Holmes HM. Tools to reduce polypharmacy. Clin Geriatr Med 2012;28:323-41.
36. Barry PJ, Gallagher P, Ryan C, et al. START (screening tool to alert doctors to the right treatment) - an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007;36:632-8.
37. Rudolph JL, Salow MJ, Angelini MC, et al. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008; 168:508-13.
38. Haque R. ARMOR: a tool to evaluate polypharmacy in elderly persons. Ann Long-Term Care 2009;17:26-30.
39. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007;9:430-4.
40. Drenth-van Maanen AC, van Marum RJ, Knol W, et al. Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners. Drugs Aging 2009; 26: 687-701.
41. Yourman LC, Lee SJ, Schonberg MA, et al. Prognostic indices for older adults: a systematic review. JAMA 2012;307:182-92.
42. Rockwood K. Frailty index predicts NH placement and death. CMAJ 2005;173:489-95.
43. Tinetti ME, McAvay GJ, Chang SS, et al. Contribution of multiple chronic conditions to universal health outcomes. J Am Geriatr Soc 2011;59:1686-91.
44. Bain KT, Holmes HM, Beers MH, et al. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc 2008;56:1946-52.
45. Scott IA, Gray L, Martin J, et al. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evid Based Med 2013;18: 121-4.
46. Schuling J, Gebben H, Veehof LJ, et al. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract 2012;13:56.
47. Reeve E, Shakib S, Wiese M. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging 2013;30:793-807.